Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy

Overview

Journal Vaccines (Basel)

Date 2021 Dec 28

PMID 34960243

Citations 25

Authors

Kajal H Gupta

Christina Nowicki

Eileena F Giurini

Amanda L Marzo

Andrew Zloza

Affiliations

Soon will be listed here.

Abstract

Currently approximately 10 million people die each year due to cancer, and cancer is the cause of every sixth death worldwide. Tremendous efforts and progress have been made towards finding a cure for cancer. However, numerous challenges have been faced due to adverse effects of chemotherapy, radiotherapy, and alternative cancer therapies, including toxicity to non-cancerous cells, the inability of drugs to reach deep tumor tissue, and the persistent problem of increasing drug resistance in tumor cells. These challenges have increased the demand for the development of alternative approaches with greater selectivity and effectiveness against tumor cells. Cancer immunotherapy has made significant advancements towards eliminating cancer. Our understanding of cancer-directed immune responses and the mechanisms through which immune cells invade tumors have extensively helped us in the development of new therapies. Among immunotherapies, the application of bacteria and bacterial-based products has promising potential to be used as treatments that combat cancer. Bacterial targeting of tumors has been developed as a unique therapeutic option that meets the ongoing challenges of cancer treatment. In comparison with other cancer therapeutics, bacterial-based therapies have capabilities for suppressing cancer. Bacteria are known to accumulate and proliferate in the tumor microenvironment and initiate antitumor immune responses. We are currently well-informed regarding various methods by which bacteria can be manipulated by simple genetic engineering or synthetic bioengineering to induce the production of anti-cancer drugs. Further, bacterial-based cancer therapy (BBCT) can be either used as a monotherapy or in combination with other anticancer therapies for better clinical outcomes. Here, we review recent advances, current challenges, and prospects of bacteria and bacterial products in the development of BBCTs.

Citing Articles

Leveraging Microorganisms to Combat Skin Cancer.

Oyler H, Callister A, Kutch M, Wakefield M, Fang Y Microorganisms. 2025; 13(2).

PMID: 40005824 PMC: 11858759. DOI: 10.3390/microorganisms13020462.

Neo-BCV: A Novel Bacterial Liquid Complex Vaccine for Enhancing Dendritic Cell-Mediated Immune Responses Against Lung Cancer.

Zhu Z, Chu Z, Fei F, Wu C, Fei Z, Sun Y Vaccines (Basel). 2025; 13(1.

PMID: 39852843 PMC: 11768841. DOI: 10.3390/vaccines13010064.

Controlling tumor progression and recurrence in mice through combined treatment with a PD-L1 inhibitor and a designer strain that delivers GM-CSF.

Jeon H, Lim D, So E, Kim S, Jeong J, Song M Acta Pharm Sin B. 2025; 14(12):5479-5492.

PMID: 39807328 PMC: 11725042. DOI: 10.1016/j.apsb.2024.07.011.

Evaluation of a three-gene methylation model for correlating lymph node metastasis in postoperative early gastric cancer adjacent samples.

Chen S, Long S, Liu Y, Wang S, Hu Q, Fu L Front Oncol. 2024; 14:1432869.

PMID: 39484038 PMC: 11524798. DOI: 10.3389/fonc.2024.1432869.

Gut Microbiota Disruption in Hematologic Cancer Therapy: Molecular Insights and Implications for Treatment Efficacy.

Guevara-Ramirez P, Cadena-Ullauri S, Paz-Cruz E, Ruiz-Pozo V, Tamayo-Trujillo R, Cabrera-Andrade A Int J Mol Sci. 2024; 25(19).

PMID: 39408584 PMC: 11476909. DOI: 10.3390/ijms251910255.

References

Zu C, Wang J . Tumor-colonizing bacteria: a potential tumor targeting therapy. Crit Rev Microbiol. 2013; 40(3):225-35. DOI: 10.3109/1040841X.2013.776511. View

Frahm M, Felgner S, Kocijancic D, Rohde M, Hensel M, Curtiss 3rd R . Efficiency of conditionally attenuated Salmonella enterica serovar Typhimurium in bacterium-mediated tumor therapy. mBio. 2015; 6(2). PMC: 4453544. DOI: 10.1128/mBio.00254-15. View

Ngo N, Choucair K, Creeden J, Qaqish H, Bhavsar K, Murphy C . : the promising Trojan Horse in the era of precision oncology. Future Oncol. 2019; 15(33):3861-3876. DOI: 10.2217/fon-2019-0374. View

Singer H, Erhardt M, Steiner A, Zhang M, Yoshikami D, Bulaj G . Selective purification of recombinant neuroactive peptides using the flagellar type III secretion system. mBio. 2012; 3(3). PMC: 3372961. DOI: 10.1128/mBio.00115-12. View

Mi Z, Feng Z, Li C, Yang X, Ma M, Rong P . -Mediated Cancer Therapy: An Innovative Therapeutic Strategy. J Cancer. 2019; 10(20):4765-4776. PMC: 6775532. DOI: 10.7150/jca.32650. View

Basu P, Mehta A, Jain M, Gupta S, Nagarkar R, John S . A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer. Int J Gynecol Cancer. 2018; 28(4):764-772. PMC: 5929492. DOI: 10.1097/IGC.0000000000001235. View

Le D, Wang-Gillam A, Picozzi V, Greten T, Crocenzi T, Springett G . Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer. J Clin Oncol. 2015; 33(12):1325-33. PMC: 4397277. DOI: 10.1200/JCO.2014.57.4244. View

Brockstedt D, Giedlin M, Leong M, Bahjat K, Gao Y, Luckett W . Listeria-based cancer vaccines that segregate immunogenicity from toxicity. Proc Natl Acad Sci U S A. 2004; 101(38):13832-7. PMC: 518841. DOI: 10.1073/pnas.0406035101. View

Veena V, Popavath R, Kennedy K, Sakthivel N . In vitro antiproliferative, pro-apoptotic, antimetastatic and anti-inflammatory potential of 2,4-diacetylphloroglucinol (DAPG) by Pseudomonas aeruginosa strain FP10. Apoptosis. 2015; 20(10):1281-95. DOI: 10.1007/s10495-015-1162-9. View

10.

Obeid M, Tesniere A, Ghiringhelli F, Fimia G, Apetoh L, Perfettini J . Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med. 2006; 13(1):54-61. DOI: 10.1038/nm1523. View

11.

Kikuchi T, Shimizu H, Akiyama Y, Taniguchi S . In situ delivery and production system of trastuzumab scFv with Bifidobacterium. Biochem Biophys Res Commun. 2017; 493(1):306-312. DOI: 10.1016/j.bbrc.2017.09.026. View

12.

Li T, Dong Z, Guo Z, Wang C, Zhi X, Zhou J . Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway. Liver Int. 2014; 35(4):1416-29. DOI: 10.1111/liv.12644. View

13.

Dang L, Bettegowda C, Huso D, Kinzler K, Vogelstein B . Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci U S A. 2001; 98(26):15155-60. PMC: 64999. DOI: 10.1073/pnas.251543698. View

14.

Kim S, Castro F, Gonzalez D, Maciag P, Paterson Y, Gravekamp C . Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases. Br J Cancer. 2008; 99(5):741-9. PMC: 2528142. DOI: 10.1038/sj.bjc.6604526. View

15.

Theys J, Lambin P . Clostridium to treat cancer: dream or reality?. Ann Transl Med. 2015; 3(Suppl 1):S21. PMC: 4437957. DOI: 10.3978/j.issn.2305-5839.2015.03.39. View

16.

Gardlik R, Fruehauf J . Bacterial vectors and delivery systems in cancer therapy. IDrugs. 2010; 13(10):701-6. View

17.

Jain R, Forbes N . Can engineered bacteria help control cancer?. Proc Natl Acad Sci U S A. 2001; 98(26):14748-50. PMC: 64926. DOI: 10.1073/pnas.261606598. View

18.

Felgner S, Kocijancic D, Frahm M, Weiss S . Bacteria in Cancer Therapy: Renaissance of an Old Concept. Int J Microbiol. 2016; 2016:8451728. PMC: 4802035. DOI: 10.1155/2016/8451728. View

19.

Zhao M, Yang M, Li X, Jiang P, Baranov E, Li S . Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci U S A. 2005; 102(3):755-60. PMC: 545558. DOI: 10.1073/pnas.0408422102. View

20.

Glomski I, Decatur A, Portnoy D . Listeria monocytogenes mutants that fail to compartmentalize listerolysin O activity are cytotoxic, avirulent, and unable to evade host extracellular defenses. Infect Immun. 2003; 71(12):6754-65. PMC: 308949. DOI: 10.1128/IAI.71.12.6754-6765.2003. View